SLAMF6 and acute myeloid leukemia: We also show that a new antibody targeting the dimerization interface on SLAMF6 can break the immunosuppressive SLAMF6–SLAMF6 interaction between AML cells and T cells and unleash a T cell response that eliminates AML cells both in vitro and in vivo.